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Air Pollution Intervention 
Study Links Use of Face Masks to Improved 
Cardiovascular Outcomes 
Air pollution from traffic and industrial 
sources increases cardiovascular morbid-
ity and mortality, especially in populations 
with underlying cardiovascular disease. 
Environmental interventions to reduce pol-
lution would be ideal, but their implementa-
tion may be hampered in countries where 
emissions reductions are trumped by eco-
nomic growth. A new study explores face 
masks as a simple and practical interven-
tion for reducing individuals’ exposure to 
particulate air pollution and finds their use 
improves several cardiovascular health mea-
sures in people with coronary heart disease 
[EHP 120(3):367–372; Langrish et al.].
Vehicle traffic and industry emit a variety 
of toxicants, including particulate matter, car-
bon monoxide, sulfur dioxide, and nitrogen 
dioxide. Previous studies have shown that 
inhaling combustion emissions may increase 
blood pressure and adversely affect vascular 
and cardiac function, plausibly explaining the 
detrimental cardiovascular effects associated 
with breathing heavily polluted urban air.
In the current study, nonsmoking patients 
with a history of coronary heart disease were 
recruited in March 2009 at 2 Beijing hospi-
tals. After participants’ health and physical 
condition were assessed, they completed 
2-hour walks around Beijing’s city center on 
2 separate days. Participants were randomly assigned to wear a highly 
efficient air-filtering mask on 1 of the 2 walks. The mask was worn 
outdoors and during much of the time indoors for 24 hours before 
the study day as well as the entire study day itself. On study days, 
participants also wore equipment to monitor 
their air pollutant exposure as well as blood 
pressure and heart function. They completed 
questionnaires on their physical symptoms, 
their perceptions of pollution levels and exer-
tion, and the tolerability of the face mask.
The 98 participants that completed 
the study tolerated the face mask well and 
reported reductions in symptoms, perceived 
exertion, and perceived pollution levels. Use 
of a face mask was also significantly associ-
ated with beneficial cardiovascular character-
istics, including reduced blood pressure and 
improved heart-rate variability.
The study was not double-blinded (in 
part because the researchers wanted to study 
the acceptability of wearing a face mask), 
and the findings may therefore be limited 
by subjective bias. The results suggest that 
face masks may effectively reduce individuals’ 
air pollutant exposure and lower associated 
cardiovascular risks. However, it is unknown 
whether these effects would be sustained with 
face-mask use over a longer period and would 
ultimately result in clinically significant 
improvement in cardiovascular health.
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BPA and PXR Activation
Human Receptor Is Affected, Mouse Receptor Is Not
The high-production-volume chemical bisphenol A (BPA) is a key 
component in polycarbonate plastics and is used in a wide variety of 
consumer products. The U.S. general population is widely exposed to 
BPA, as demonstrated by the chemical’s presence in more than 90% 
of biological samples tested. BPA has been associated with cardiovas-
cular disease and diabetes in human population studies, but if causal-
ity were to be proven, it is doubtful it would arise from BPA’s known 
weak interaction with estrogen receptors. Researchers previously 
determined that BPA targets another nuclear receptor, the pregnane X 
receptor (PXR), and have now determined that the chemical and sev-
eral related compounds (“analogues”) can induce metabolically impor-
tant genes via PXR activation [EHP 120(3):399–405; Sui et al.].
PXR is activated by numerous endogenous and environmental 
chemicals. Earlier research established that PXR activation in mice 
and rats induces genes involved in lipid homeostasis, atherosclerosis, 
and carcinogenesis. Although PXR is not affected by BPA in rodents, 
the chemical activates the human receptor and induces target gene 
expression. This connection suggested a possible mechanism to explain 
BPA-related cardiovascular disease findings in human populations.
In the current study, transfection assays using mouse- and human-
derived receptors showed that BPA induces strong, dose-dependent 
activation of human PXR but not mouse PXR. Computational docking 
and modeling studies focusing on the structure of human PXR identi-
fied key amino acids within the ligand-binding domain that permit 
BPA to interact with the receptor. These studies also highlighted how 
species-related differences in this domain can affect how different spe-
cies respond to specific chemicals.
The modeled predictions were confirmed in vitro using site-directed 
mutagenesis assays that focused on the amino acids critical for BPA 
docking within PXR. Additionally, several BPA structural analogues 
were found to activate the PXR. Experiments to determine interactions 
between BPA and specific analogues showed synergism when BPA was 
paired with 2-(4'-hydroxyphenyl)-2-phenylpropane (HPP); that is, the 
effect of the mixture exceeded the sum of the individual chemicals. In a 
final set of experiments, the ability of BPA and analogues HPP and bis-
phenol B to separately trigger expression of PXR target genes was tested 
in a human intestinal cell line. All 3 compounds were found to trigger 
expression of the metabolic genes CYP3A4, UGT1A1, and MDR1.
Although this study did not address questions of risk assessment, its 
findings suggest that BPA may adversely affect human health via PXR 
and thus provide a foundation for further exploration of the observed 
association between BPA and cardiovascular disease. Additionally, 
given the likelihood that real-life exposures involve chemical mixtures, 
the demonstrated synergism between BPA and HPP supports the need 
to include mixtures in in vivo experiments.
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During their walks through the city center, 
subjects wore backpacks equipped with 
air monitors.